Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022

SELL
$30.7 - $43.36 $1,197 - $1,691
-39 Reduced 27.66%
102 $4,000
Q3 2021

Oct 21, 2021

SELL
$19.91 - $68.26 $79 - $273
-4 Reduced 2.76%
141 $5,000
Q2 2021

Jul 16, 2021

BUY
$50.63 - $73.5 $1,468 - $2,131
29 Added 25.0%
145 $10,000
Q1 2021

Apr 14, 2021

BUY
$55.91 - $81.44 $6,485 - $9,447
116 New
116 $7,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Farmers & Merchants Investments Inc Portfolio

Follow Farmers & Merchants Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Investments Inc with notifications on news.